Another open-label RCT observed that dulaglutide (another GLP-1 receptor agonist) led to greater reduction of binge-eating behaviour compared to gliclazide in people with T2D and BED [21]
Part of the literature was retrieved from the previous study (
Factors such as poor diet, chronic illness, pollution exposure, and aging can reduce natural glutathione levels
A patch that delivers only 1030% of the dose needed creates a subtherapeutic effect, leaving patients hungry and without the metabolic benefits of higher doses
You can search for trials based on the type of cancer, the age of the patient, and where the trials are being done
The progression of colitis was monitored using the Disease Activity Index (DAI) scoring system (Yao et al., 2020), which assesses the severity of colitis based on specific parameters